ArticleHeliyon2022
A new accelerometer (Fibion) device provides valid sedentary and upright time measurements compared to the ActivPAL4 in healthy individuals.
Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 18 citations in OpenAlex.
- Association Between Sedentary Behavior Patterns and Glycemic Outcomes in Women with Overweight and Obesity Under Free-Living Conditions.International journal of behavioral medicine · 2026Article
- Wearable Sensors and Artificial Intelligence for Ecological Knee Osteoarthritis Assessment: Development and Feasibility of a Hybrid Digital Phenotyping Framework.Sensors (Basel, Switzerland) · 2026Article
- Physical activity patterns in chronic kidney disease.BMC nephrology · 2026Observational
- Article
- Do COVID-19 recovered individuals differ from healthy controls in accelerometer-measured physical activity and self-reported sleep? a UAE-based study.BMC public health · 2025Article
- Enhancing physical activity during pregnancy using a multi-theory model: a study protocol for a randomised controlled trial in China.BMJ open · 2025Article
- Inter-monitor reliability and validity of the fibion accelerometers in a laboratory-based study of functional activities.PloS one · 2025Article
- Concurrent validity between self-reported International Physical Activity Questionnaire Short Form and Fibion accelerometer data among young adults in the UAE.European journal of medical research · 2024Article
- Charting the cascade of physical activities: implications for reducing sitting time and obesity in children.Journal of activity, sedentary and sleep behaviors · 2024Article
- Article
- Human-Centric Lighting Research and Policy in the Melanopsin Age.Policy insights from the behavioral and brain sciences · 2023Article
- Sensitivity and specificity of measuring children's free-living cycling with a thigh-worn Fibion® accelerometer.Frontiers in sports and active living · 2023Article
- Association of sociodemographic, anthropometric, and sleep quality factors with accelerometer-measured sitting and physical activity times among Emirati working women during the COVID-19 pandemic: A cross-sectional study.Women's health (London, England)Article
Corrections and comments
- Erratum issued
Authors and funding
3 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Thigh-worn accelerometers can accurately measure time spent sitting, standing and walking in free-living settings. Aim: To investigate the concurrent validity of a new Fibion accelerometer and a validated ActivPAL4 accelerometer for estimating sedentary and upright time in healthy individuals. Methods: A total of 29 healthy individuals, aged between 18 and 50 years, wore the Fibion and ActivPAL4 devices on the same thigh with a medical adhesive tape during one typical weekday. Concurrent validity of the Fibion and ActivPAL4 was assessed by comparing time spent in sitting, walking and standing using intraclass correlation coefficient and Bland-Altman plots. Results: Intraclass correlation coefficients were ≥0.843 which indicated good to excellent validity between the two devices for measuring sedentary (sitting) and upright (standing and walking) time. Analysis of the Bland Altman plots revealed a reasonable agreement for sitting, standing and walking time between both devices. No proportional bias was evident in the Bland-Altman plots. Conclusion: The Fibion demonstrated good to excellent validity in measuring sedentary and upright time compared to the ActivPAL4 in healthy individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.